What is ASP Isotopes' operating income?

ASP Isotopes' total operating income in 2025 was -$59.91 million, based on the following breakdown: Total Gross Profit: $3.41 million Total Operating Expenses: $63.31 million

ASP Isotopes (ASPI) Financials

$3.88 -0.06 (-1.52%)

Closing price 04:00 PM Eastern

Extended Trading

$3.90 +0.02 (+0.64%)

As of 07:58 PM Eastern

Compare

Annual Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-4.95	-16	-35	-175
Consolidated Net Income / (Loss)	-4.95	-16	-32	-160
Net Income / (Loss) Continuing Operations	-4.95	-16	-32	-160
Total Pre-Tax Income	-4.95	-16	-32	-160
Total Operating Income	-5.10	-16	-26	-60
Total Gross Profit	0.00	0.14	1.60	3.41
Total Revenue	0.00	0.43	4.14	24
Operating Revenue	0.00	0.43	4.14	24
Total Cost of Revenue	0.00	0.29	2.55	20
Operating Cost of Revenue	0.00	0.29	2.55	20
Total Operating Expenses	5.10	16	28	63
Selling, General & Admin Expense	3.83	15	25	48
Research & Development Expense	1.27	0.76	3.14	15
Total Other Income / (Expense), net	0.15	-0.26	-5.96	-100
Interest Expense	0.00	0.12	0.26	0.58
Interest & Investment Income	0.00	0.01	1.24	6.79
Other Income / (Expense), net	0.15	-0.15	-6.94	-106
Income Tax Expense	0.00	-0.01	0.11	0.28
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-0.01	-0.09	15
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	0.00
Basic Earnings per Share	-	($0.49)	($0.63)	($2.11)
Weighted Average Basic Shares Outstanding	26.79M	33.07M	55.67M	83.01M
Diluted Earnings per Share	-	($0.49)	($0.63)	($2.11)
Weighted Average Diluted Shares Outstanding	26.79M	33.07M	55.67M	83.01M

This table shows ASP Isotopes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-4.22	-4.16	-6.95	-12	-7.27	-9.18	-8.45	-75	-13	-79	-6.88
Consolidated Net Income / (Loss)	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22	-8.46	-75	-13	-63	-7.12
Net Income / (Loss) Continuing Operations	-4.22	-4.17	-6.96	-8.88	-7.36	-9.13	-8.46	-75	-13	-63	-27
Total Pre-Tax Income	-4.22	-4.18	-7.01	-8.87	-7.36	-9.07	-8.53	-75	-13	-63	-27
Total Operating Income	-3.95	-4.02	-5.81	-7.46	-5.43	-7.65	-7.95	-12	-15	-25	-25
Total Gross Profit	0.00	0.14	0.28	0.42	0.29	0.61	0.33	0.57	0.42	2.08	1.67
Total Revenue	0.00	0.43	0.84	1.02	1.09	1.19	1.10	1.20	4.89	17	4.18
Operating Revenue	0.00	0.43	0.84	1.02	1.09	1.19	1.10	1.20	4.89	17	4.18
Total Cost of Revenue	0.00	0.29	0.56	0.60	0.79	0.59	0.78	0.63	4.47	15	2.51
Operating Cost of Revenue	0.00	0.29	0.56	0.60	0.79	0.59	0.78	0.63	4.47	15	2.51
Total Operating Expenses	3.95	4.16	6.09	7.88	5.73	8.25	8.28	13	15	27	27
Selling, General & Admin Expense	3.71	4.10	5.88	7.41	4.69	6.84	6.75	12	12	18	21
Research & Development Expense	0.24	0.07	0.22	0.47	1.03	1.42	1.53	0.88	3.10	9.57	5.26
Total Other Income / (Expense), net	-0.28	-0.15	-1.20	-1.41	-1.93	-1.42	-0.58	-63	2.15	-38	-1.85
Interest Expense	0.00	0.12	0.01	0.07	0.09	0.09	0.09	0.08	0.15	0.26	1.73
Interest & Investment Income	0.00	0.00	0.01	0.04	0.60	0.58	0.51	0.93	1.84	3.51	3.05
Other Income / (Expense), net	-0.28	-0.04	-1.20	-1.38	-2.44	-1.92	-1.01	-64	0.45	-41	-3.17
Income Tax Expense	0.00	-0.01	-0.05	0.01	-0.01	0.06	-0.07	0.10	0.07	0.18	-0.03
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	0.00	-	-	-	20
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-0.01	-0.02	0.05	-0.08	-0.04	-0.02	-0.09	-0.02	15	-0.24
Basic Earnings per Share	($0.14)	-	($0.16)	($0.24)	($0.12)	-	($0.12)	($1.03)	($0.15)	($0.81)	($0.06)
Weighted Average Basic Shares Outstanding	31.15M	33.07M	44.56M	49.14M	61.53M	55.67M	69.48M	73.01M	88.55M	83.01M	121.00M
Diluted Earnings per Share	($0.14)	-	($0.16)	($0.24)	($0.12)	-	($0.12)	($1.03)	($0.15)	($0.81)	($0.06)
Weighted Average Diluted Shares Outstanding	31.15M	33.07M	44.56M	49.14M	61.53M	55.67M	69.48M	73.01M	88.55M	83.01M	121.00M
Weighted Average Basic & Diluted Shares Outstanding	31.15M	33.07M	44.56M	49.14M	71.39M	72.07M	75.06M	91.91M	110.84M	0.00	125.90M

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-0.77	5.52	54	223
Net Cash From Operating Activities	-2.94	-5.41	-17	-38
Net Cash From Continuing Operating Activities	-2.94	-5.41	-17	-38
Net Income / (Loss) Continuing Operations	-4.95	-16	-32	-160
Consolidated Net Income / (Loss)	-4.95	-16	-32	-160
Depreciation Expense	0.00	0.04	0.47	1.91
Non-Cash Adjustments To Reconcile Net Income	1.93	9.58	18	124
Changes in Operating Assets and Liabilities, net	0.07	1.26	-2.77	-3.70
Net Cash From Investing Activities	-4.47	-2.45	-11	-111
Net Cash From Continuing Investing Activities	-4.47	-2.45	-11	-111
Purchase of Property, Plant & Equipment	-4.47	-2.33	-11	-9.65
Acquisitions	0.00	-0.12	0.00	4.57
Purchase of Investments	-	-	0.00	-76
Other Investing Activities, net	-	0.00	0.00	-30
Net Cash From Financing Activities	6.64	13	83	372
Net Cash From Continuing Financing Activities	6.64	13	83	372
Repayment of Debt	0.00	-0.70	-0.61	-16
Repurchase of Common Equity	-1.47	-0.56	-3.65	-18
Payment of Dividends	-	-	-	0.00
Issuance of Debt	0.00	0.53	26	60
Issuance of Common Equity	8.12	14	53	341
Other Financing Activities, net	-0.01	-0.01	7.27	4.14
Cash Income Taxes Paid	-	-	0.00	0.08

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.47	5.57	16	6.53	23	11	-5.75	11	46	171	-72
Net Cash From Operating Activities	-0.65	-2.06	-2.97	-5.12	-4.84	-3.76	-3.17	-7.90	-8.86	-18	-18
Net Cash From Continuing Operating Activities	0.17	-2.06	-2.97	-0.60	-7.30	-3.76	-3.17	-7.90	-8.86	-18	-17
Net Income / (Loss) Continuing Operations	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22	-8.46	-75	-13	-63	-7.37
Consolidated Net Income / (Loss)	-4.22	-4.17	-6.96	-8.88	-7.36	-9.22	-8.46	-75	-13	-63	-7.12
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	0.00	-	-	-	0.25
Depreciation Expense	0.00	0.04	0.10	0.15	0.18	0.05	0.15	0.53	0.30	0.94	3.06
Non-Cash Adjustments To Reconcile Net Income	2.90	2.16	3.56	5.88	5.91	4.65	3.30	69	3.72	48	-6.10
Changes in Operating Assets and Liabilities, net	1.52	-0.09	0.33	2.36	-6.04	0.76	1.84	-1.81	0.02	-3.85	-6.22
Net Cash From Discontinued Operating Activities	-	-	-	-	-	-	0.00	-	-	-	-1.12
Net Cash From Investing Activities	-0.68	-1.26	-1.25	-2.62	-4.48	-3.02	-2.36	-32	-1.50	-75	-97
Net Cash From Continuing Investing Activities	-0.68	-1.26	-1.25	-2.62	-4.48	-3.02	-2.36	-32	-1.50	-75	-97
Purchase of Property, Plant & Equipment	-0.68	-1.14	-1.25	-2.62	-4.48	-1.32	-2.36	-1.80	-3.15	-2.40	-6.14
Acquisitions	-	-	-	-	-	-	0.00	-	-	-2.07	-46
Purchase of Investments	-	-	-	-	-	-	0.00	-	-	-71	-45
Other Investing Activities, net	-	-	0.00	-	-	-	0.00	-30	-	0.03	0.16
Net Cash From Discontinued Investing Activities	-	-	-	-	-	-	0.00	-	-	-	0.00
Net Cash From Financing Activities	-	8.89	20	12	32	18	-0.23	51	57	264	43
Net Cash From Continuing Financing Activities	-	8.89	20	12	32	18	-0.23	51	57	264	-2.72
Repayment of Debt	-	-0.70	-0.26	-0.18	-	-0.17	-0.25	-0.55	-2.58	-13	-2.09
Issuance of Debt	-	0.53	21	5.39	-	0.50	0.05	0.00	3.35	57	0.05
Other Financing Activities, net	-	-0.01	-0.02	1.48	5.57	0.23	-0.02	4.79	-0.37	-0.27	-0.68
Net Cash From Discontinued Financing Activities	-	-	-	-	-	-	0.00	-	-	-	46

This table presents ASP Isotopes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	12	28	94	498
Total Current Assets	3.30	11	66	400
Cash & Equivalents	2.39	7.91	62	280
Restricted Cash	-	-	-	0.00
Short-Term Investments	-	-	0.00	48
Note & Lease Receivable	-	-	0.00	32
Accounts Receivable	0.00	0.22	0.71	1.08
Inventories, net	-	0.00	0.07	1.10
Prepaid Expenses	0.91	1.66	3.05	4.95
Other Current Assets	0.00	0.72	0.03	1.78
Other Current Nonoperating Assets	-	-	-	32
Plant, Property, & Equipment, net	8.20	11	22	33
Total Noncurrent Assets	0.99	6.32	6.25	65
Long-Term Investments	-	-	0.00	5.58
Noncurrent Note & Lease Receivables	-	-	0.00	0.43
Goodwill	0.00	3.27	3.17	5.18
Intangible Assets	-	-	0.00	0.41
Noncurrent Deferred & Refundable Income Taxes	-	0.00	0.03	0.00
Other Noncurrent Operating Assets	0.99	3.05	3.05	2.33
Other Noncurrent Nonoperating Assets	-	-	-	51
Total Liabilities & Shareholders' Equity	12	28	94	498
Total Liabilities	2.68	8.71	43	235
Total Current Liabilities	1.94	5.67	7.06	33
Short-Term Debt	0.03	0.47	0.94	0.58
Accounts Payable	1.35	1.11	1.02	3.81
Accrued Expenses	0.36	1.31	2.28	4.41
Current Deferred Revenue	0.00	0.88	0.88	0.88
Other Current Liabilities	0.19	1.90	1.94	1.21
Other Current Nonoperating Liabilities	-	-	-	22
Total Noncurrent Liabilities	0.74	3.04	36	202
Long-Term Debt	-	0.00	33	201
Noncurrent Deferred Revenue	-	-	-	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.11	0.00	0.00
Other Noncurrent Operating Liabilities	0.74	2.93	2.69	1.53
Other Noncurrent Nonoperating Liabilities	-	-	-	0.10
Commitments & Contingencies	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	9.82	19	51	263
Total Preferred & Common Equity	9.82	16	48	204
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	9.82	16	48	204
Common Stock	17	41	106	433
Retained Earnings	-7.55	-24	-56	-231
Treasury Stock	-	-	-	0.00
Accumulated Other Comprehensive Income / (Loss)	0.26	-0.92	-2.16	2.54
Noncontrolling Interest	0.00	2.53	3.27	59

This table presents ASP Isotopes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	12	45	55	84	91	136	226	588
Total Current Assets	2.73	26	32	56	59	102	174	309
Cash & Equivalents	2.29	24	28	52	56	68	114	207
Restricted Cash	-	-	-	-	-	-	-	2.77
Short-Term Investments	-	-	-	-	-	-	-	83
Note & Lease Receivable	-	-	-	-	-	30	31	0.00
Accounts Receivable	-	0.35	0.52	0.56	0.69	0.65	17	2.39
Inventories, net	-	-	-	0.08	0.34	1.05	1.37	1.37
Prepaid Expenses	0.44	1.93	3.25	3.87	2.03	1.83	10	8.73
Other Current Assets	-	0.00	0.05	0.00	0.00	0.02	0.02	2.96
Other Current Nonoperating Assets	-	-	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	8.35	14	18	23	25	28	31	92
Total Noncurrent Assets	0.80	4.85	4.91	5.05	6.47	6.73	21	187
Long-Term Investments	-	-	-	-	-	-	6.32	40
Noncurrent Note & Lease Receivables	-	-	-	-	-	0.38	0.41	3.91
Goodwill	-	3.17	3.29	3.46	3.26	3.36	6.85	6.39
Intangible Assets	-	-	-	-	-	-	1.19	0.68
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	0.11	0.03	0.07	0.07
Other Noncurrent Operating Assets	0.80	1.68	1.63	1.59	3.09	2.95	6.07	136
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	0.00
Total Liabilities & Shareholders' Equity	12	45	55	84	91	136	226	588
Total Liabilities	3.23	32	40	42	45	108	129	289
Total Current Liabilities	2.60	7.33	8.01	7.43	8.18	6.90	28	70
Short-Term Debt	0.03	0.21	0.03	0.03	0.77	0.34	12	53
Accounts Payable	0.40	2.22	2.43	1.80	2.05	2.60	3.42	6.87
Accrued Expenses	1.09	1.77	2.46	1.76	3.05	1.79	3.66	7.90
Current Deferred Revenue	0.88	0.88	0.88	0.88	0.88	0.88	0.88	0.88
Other Current Liabilities	0.19	2.25	2.21	2.95	1.43	1.29	7.96	1.46
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	0.00
Total Noncurrent Liabilities	0.63	25	32	35	37	101	101	218
Long-Term Debt	-	22	29	32	36	98	100	205
Noncurrent Deferred Revenue	-	-	-	-	-	-	-	0.82
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.06	0.07	0.08	-	-	0.31	5.98
Other Noncurrent Operating Liabilities	0.63	2.95	3.23	2.83	1.11	2.55	1.14	6.53
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	0.00
Commitments & Contingencies	-	-	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	8.64	13	14	42	46	28	97	299
Total Preferred & Common Equity	8.64	11	11	39	43	25	74	289
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	8.64	11	11	39	43	25	74	289
Common Stock	30	43	51	85	108	165	226	530
Retained Earnings	-20	-31	-40	-47	-65	-140	-153	-239
Treasury Stock	-	-	-	-	-	-	-	0.00
Accumulated Other Comprehensive Income / (Loss)	-1.29	-1.46	-0.70	0.60	-0.99	0.03	0.95	-2.66
Noncontrolling Interest	-	2.51	3.35	3.32	3.21	3.08	23	10

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	110,840,122.00
DEI Adjusted Shares Outstanding	-	-	-	110,840,122.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-1.58
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	0.00%	857.04%	475.51%
EBITDA Growth	0.00%	-226.43%	-103.18%	-399.28%
EBIT Growth	0.00%	-227.18%	-105.62%	-397.96%
NOPAT Growth	0.00%	-214.61%	-64.28%	-127.32%
Net Income Growth	0.00%	-229.50%	-98.98%	-392.99%
EPS Growth	0.00%	0.00%	-28.57%	-234.92%
Operating Cash Flow Growth	0.00%	-84.10%	-208.47%	-126.28%
Free Cash Flow Firm Growth	0.00%	0.00%	-102.53%	-267.31%
Invested Capital Growth	0.00%	52.67%	107.57%	299.56%
Revenue Q/Q Growth	0.00%	0.00%	22.49%	184.48%
EBITDA Q/Q Growth	0.00%	-1,667,112.69%	-20.10%	-51.83%
EBIT Q/Q Growth	0.00%	0.00%	-19.80%	-52.16%
NOPAT Q/Q Growth	0.00%	0.00%	-15.95%	-40.84%
Net Income Q/Q Growth	0.00%	0.00%	-18.45%	-51.18%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-49.65%
Operating Cash Flow Q/Q Growth	0.00%	-28.34%	-11.36%	-59.48%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	3.38%	-17.76%
Invested Capital Q/Q Growth	0.00%	78.39%	6.28%	7.07%
Profitability Metrics	-	-	-	-
Gross Margin	0.00%	32.09%	38.60%	14.28%
EBITDA Margin	0.00%	-3,730.34%	-791.94%	-687.09%
Operating Margin	0.00%	-3,704.63%	-635.91%	-251.20%
EBIT Margin	0.00%	-3,738.99%	-803.31%	-695.11%
Profit (Net Income) Margin	0.00%	-3,762.85%	-782.36%	-670.23%
Tax Burden Percent	100.00%	99.96%	100.34%	100.18%
Interest Burden Percent	99.93%	100.68%	97.06%	96.25%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-119.11%	-105.29%	-70.99%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-15.68%	-25.33%	49.37%
Return on Net Nonoperating Assets (RNNOA)	0.00%	5.36%	12.65%	-30.80%
Return on Equity (ROE)	-100.74%	-113.75%	-92.64%	-101.79%
Cash Return on Invested Capital (CROIC)	0.00%	-160.81%	-175.24%	-190.92%
Operating Return on Assets (OROA)	0.00%	-80.88%	-54.62%	-55.97%
Return on Assets (ROA)	0.00%	-81.39%	-53.20%	-53.97%
Return on Common Equity (ROCE)	-100.74%	-103.69%	-84.96%	-81.69%
Return on Equity Simple (ROE_SIMPLE)	-50.37%	-99.99%	-67.69%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.57	-11	-18	-42
NOPAT Margin	0.00%	-2,593.24%	-445.14%	-175.84%
Net Nonoperating Expense Percent (NNEP)	-58.41%	-103.43%	-79.96%	-120.36%
Return On Investment Capital (ROIC_SIMPLE)	-	-58.18%	-21.57%	-8.83%
Cost of Revenue to Revenue	0.00%	67.91%	61.40%	85.72%
SG&A Expenses to Revenue	0.00%	3,560.15%	598.77%	202.26%
R&D to Revenue	0.00%	176.57%	75.74%	63.21%
Operating Expenses to Revenue	0.00%	3,736.72%	674.51%	265.47%
Earnings before Interest and Taxes (EBIT)	-4.95	-16	-33	-166
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.95	-16	-33	-164
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	5.36	6.75	2.90
Price to Tangible Book Value (P/TBV)	0.00	6.70	7.23	3.06
Price to Revenue (P/Rev)	0.00	201.61	78.04	24.86
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	7.23	12.65	5.12
Enterprise Value to Revenue (EV/Rev)	0.00	190.29	72.18	20.27
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.03	0.67	0.81
Long-Term Debt to Equity	0.00	0.00	0.65	0.76
Financial Leverage	-0.24	-0.34	-0.50	-0.62
Leverage Ratio	1.27	1.40	1.74	1.89
Compound Leverage Factor	1.27	1.41	1.69	1.82
Debt to Total Capital	0.34%	2.44%	40.18%	44.67%
Short-Term Debt to Total Capital	0.34%	2.44%	1.10%	2.71%
Long-Term Debt to Total Capital	0.00%	0.00%	39.09%	41.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	13.13%	3.82%	12.37%
Common Equity to Total Capital	99.66%	84.43%	56.00%	42.97%
Debt to EBITDA	-0.01	-0.03	-1.05	-1.30
Net Debt to EBITDA	0.48	0.46	0.84	1.03
Long-Term Debt to EBITDA	0.00	0.00	-1.02	-1.22
Debt to NOPAT	-0.01	-0.04	-1.86	-5.06
Net Debt to NOPAT	0.66	0.66	1.49	4.02
Long-Term Debt to NOPAT	0.00	0.00	-1.81	-4.75
Altman Z-Score	0.00	3.09	3.29	0.70
Noncontrolling Interest Sharing Ratio	0.00%	8.85%	8.29%	19.75%
Liquidity Ratios	-	-	-	-
Current Ratio	1.71	1.85	9.31	12.23
Quick Ratio	1.23	1.43	8.87	11.72
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-15	-31	-113
Operating Cash Flow to CapEx	-65.72%	-232.16%	-172.56%	-391.34%
Free Cash Flow to Firm to Interest Expense	0.00	-127.88	-118.61	-196.14
Operating Cash Flow to Interest Expense	0.00	-45.66	-64.49	-65.70
Operating Cash Flow Less CapEx to Interest Expense	0.00	-65.32	-101.87	-82.49
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.02	0.07	0.08
Accounts Receivable Turnover	0.00	0.00	8.98	2.57
Inventory Turnover	0.00	0.00	0.00	35.13
Fixed Asset Turnover	0.00	0.05	0.25	0.85
Accounts Payable Turnover	0.00	0.24	2.39	6.03
Days Sales Outstanding (DSO)	0.00	0.00	40.67	142.25
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	10.39
Days Payable Outstanding (DPO)	0.00	1,530.92	152.99	60.49
Cash Conversion Cycle (CCC)	0.00	-1,530.92	-112.33	92.15
Capital & Investment Metrics	-	-	-	-
Invested Capital	7.46	11	24	94
Invested Capital Turnover	0.00	0.05	0.24	0.40
Increase / (Decrease) in Invested Capital	0.00	3.93	12	71
Enterprise Value (EV)	0.00	82	299	483
Market Capitalization	0.00	87	323	593
Book Value per Share	$0.37	$0.33	$0.67	$1.84
Tangible Book Value per Share	$0.37	$0.27	$0.63	$1.75
Total Capital	9.85	19	86	475
Total Debt	0.03	0.47	34	212
Total Long-Term Debt	0.00	0.00	33	199
Net Debt	-2.36	-7.44	-28	-168
Capital Expenditures (CapEx)	4.47	2.33	9.68	9.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.99	-2.60	-2.27	47
Debt-free Net Working Capital (DFNWC)	1.40	5.31	60	380
Net Working Capital (NWC)	1.37	4.84	59	367
Net Nonoperating Expense (NNE)	1.38	5.06	14	118
Net Nonoperating Obligations (NNO)	-2.36	-7.44	-28	-168
Total Depreciation and Amortization (D&A)	0.00	0.04	0.47	1.91
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-600.77%	-54.67%	196.23%
Debt-free Net Working Capital to Revenue	0.00%	1,225.49%	1,438.74%	1,593.81%
Net Working Capital to Revenue	0.00%	1,116.86%	1,416.08%	1,539.78%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.63)	($2.11)
Adjusted Weighted Average Basic Shares Outstanding	0.00	33.07M	55.67M	83.01M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.63)	($2.11)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	33.07M	55.67M	83.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	33.07M	72.07M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-3.57	-11	-18	-42
Normalized NOPAT Margin	0.00%	-2,593.24%	-445.14%	-175.84%
Pre Tax Income Margin	0.00%	-3,764.27%	-779.67%	-669.05%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	-136.58	-128.60	-288.31
NOPAT to Interest Expense	0.00	-94.73	-71.26	-72.93
EBIT Less CapEx to Interest Expense	0.00	-156.24	-165.98	-305.10
NOPAT Less CapEx to Interest Expense	0.00	-114.39	-108.64	-89.72
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-29.63%	-3.46%	-11.25%	-11.24%

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	110,840,122.00	110,840,122.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	110,840,122.00	110,840,122.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-0.71	-0.06
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	175.71%	31.09%	17.22%	349.53%	1,295.68%	279.31%
EBITDA Growth	-115.98%	0.00%	-89.22%	-103.56%	-82.22%	-136.43%	-27.54%	-766.82%	-84.72%	-587.75%	-183.78%
EBIT Growth	-116.02%	0.00%	-93.91%	-106.23%	-86.35%	-135.43%	-27.78%	-758.45%	-84.36%	-594.28%	-213.18%
NOPAT Growth	-101.99%	0.00%	-56.11%	-71.53%	-37.68%	-90.10%	-36.76%	-60.49%	-175.45%	-227.14%	-212.98%
Net Income Growth	-7.92%	0.00%	-92.66%	-107.20%	-74.20%	-121.12%	-21.49%	-746.23%	-75.29%	-586.79%	15.84%
EPS Growth	-133.33%	0.00%	0.00%	0.00%	14.29%	0.00%	25.00%	-329.17%	-25.00%	-636.36%	50.00%
Operating Cash Flow Growth	0.00%	-138.65%	-105.57%	-307.72%	-640.92%	-82.76%	-6.72%	-54.18%	-83.00%	-374.71%	-460.25%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	-114.98%	-161.00%	-33.46%	-155.81%	-288.81%	-401.75%	-941.87%
Invested Capital Growth	0.00%	52.67%	0.00%	0.00%	248.42%	107.57%	132.27%	288.51%	296.59%	299.56%	747.08%
Revenue Q/Q Growth	0.00%	0.00%	94.07%	21.65%	6.40%	9.76%	-7.73%	8.78%	308.02%	240.72%	-74.91%
EBITDA Q/Q Growth	1.09%	4.73%	-69.15%	-27.71%	11.46%	-23.62%	7.44%	-755.59%	81.13%	-360.26%	61.81%
EBIT Q/Q Growth	1.43%	3.88%	-72.60%	-26.12%	10.94%	-21.44%	6.32%	-747.28%	80.87%	-357.32%	57.74%
NOPAT Q/Q Growth	9.22%	-1.94%	-44.53%	-28.25%	27.14%	-40.75%	-3.98%	-50.50%	-25.05%	-67.17%	0.53%
Net Income Q/Q Growth	1.49%	1.24%	-13,426.27%	-27.52%	17.18%	-25.36%	8.24%	-788.23%	82.84%	-391.18%	88.76%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-758.33%	85.44%	-440.00%	92.59%
Operating Cash Flow Q/Q Growth	48.03%	-214.91%	-44.39%	-72.52%	5.55%	22.32%	15.69%	-149.26%	-12.10%	-101.53%	0.51%
Free Cash Flow Firm Q/Q Growth	0.00%	26.26%	-128.71%	-32.45%	3.76%	10.47%	-16.94%	-153.88%	-46.27%	-15.54%	-232.34%
Invested Capital Q/Q Growth	0.00%	78.39%	-0.29%	33.96%	46.23%	6.28%	11.58%	124.06%	49.27%	7.07%	216.18%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	32.09%	33.18%	41.18%	27.03%	50.74%	29.67%	47.74%	8.65%	12.50%	39.86%
EBITDA Margin	0.00%	-929.61%	-810.25%	-850.59%	-707.83%	-797.18%	-799.72%	-6,289.94%	-290.86%	-392.91%	-598.04%
Operating Margin	0.00%	-929.07%	-691.95%	-729.48%	-499.55%	-640.58%	-721.89%	-998.76%	-306.10%	-150.19%	-595.41%
EBIT Margin	0.00%	-938.03%	-834.28%	-864.93%	-724.01%	-801.01%	-813.24%	-6,334.16%	-296.92%	-398.54%	-671.17%
Profit (Net Income) Margin	0.00%	-963.04%	-828.80%	-868.77%	-676.24%	-772.36%	-768.10%	-6,271.75%	-263.70%	-380.15%	-170.36%
Tax Burden Percent	100.00%	99.85%	99.32%	100.16%	99.89%	101.69%	99.17%	100.13%	100.57%	100.29%	26.63%
Interest Burden Percent	99.92%	102.82%	100.02%	100.29%	93.51%	94.82%	95.24%	98.89%	88.30%	95.11%	95.30%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-29.87%	-108.59%	-154.06%	-82.62%	-106.06%	-117.95%	-86.17%	-32.51%	-42.44%	-89.82%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-2.22%	238.73%	-1,009.54%	-50.35%	-83.93%	-90.39%	-507.93%	-15.32%	4.33%	-111.54%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.76%	-30.54%	-60.17%	21.88%	41.92%	32.32%	-376.93%	3.11%	-2.70%	30.69%
Return on Equity (ROE)	0.00%	-29.11%	-139.13%	-214.23%	-60.74%	-64.15%	-85.63%	-463.11%	-29.40%	-45.14%	-59.13%
Cash Return on Invested Capital (CROIC)	0.00%	-160.81%	-423.45%	-395.42%	-221.91%	-175.24%	-185.29%	-180.27%	-173.34%	-190.92%	-200.81%
Operating Return on Assets (OROA)	0.00%	-20.29%	-46.81%	-72.52%	-51.03%	-54.47%	-52.59%	-304.39%	-16.06%	-32.09%	-53.27%
Return on Assets (ROA)	0.00%	-20.83%	-46.51%	-72.84%	-47.67%	-52.52%	-49.67%	-301.39%	-14.26%	-30.61%	-13.52%
Return on Common Equity (ROCE)	0.00%	-26.54%	-112.33%	-164.26%	-56.76%	-58.83%	-77.29%	-393.33%	-23.92%	-36.23%	-56.86%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-186.77%	-220.12%	-70.74%	0.00%	-79.79%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.76	-2.82	-4.07	-5.22	-3.80	-5.35	-5.57	-8.38	-10	-18	-17
NOPAT Margin	0.00%	-650.35%	-484.36%	-510.64%	-349.69%	-448.41%	-505.32%	-699.13%	-214.27%	-105.13%	-416.78%
Net Nonoperating Expense Percent (NNEP)	-129.60%	-27.65%	-347.31%	855.48%	-32.27%	-22.13%	-27.56%	421.76%	-17.19%	-46.77%	21.72%
Return On Investment Capital (ROIC_SIMPLE)	-	-14.59%	-	-	-	-6.26%	-6.76%	-6.61%	-5.02%	-3.69%	-3.13%
Cost of Revenue to Revenue	0.00%	67.91%	66.82%	58.82%	72.97%	49.26%	70.33%	52.26%	91.35%	87.50%	60.14%
SG&A Expenses to Revenue	0.00%	946.11%	699.53%	724.37%	431.48%	572.71%	612.69%	973.07%	251.39%	105.26%	509.35%
R&D to Revenue	0.00%	15.05%	25.60%	46.30%	95.10%	118.61%	138.87%	73.43%	63.37%	57.43%	125.91%
Operating Expenses to Revenue	0.00%	961.16%	725.13%	770.66%	526.58%	691.32%	751.56%	1,046.50%	314.76%	162.69%	635.26%
Earnings before Interest and Taxes (EBIT)	-4.23	-4.06	-7.01	-8.84	-7.87	-9.56	-8.96	-76	-15	-66	-28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.23	-4.03	-6.81	-8.70	-7.70	-9.52	-8.81	-75	-14	-65	-25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	5.36	19.15	14.38	4.79	6.75	7.95	21.90	11.94	2.90	1.70
Price to Tangible Book Value (P/TBV)	0.00	6.70	27.40	20.51	5.26	7.23	8.61	25.26	13.39	3.06	1.74
Price to Revenue (P/Rev)	0.00	201.61	158.19	69.00	54.79	78.04	76.72	120.58	105.47	24.86	18.19
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	7.23	17.81	10.69	7.59	12.65	12.20	9.92	10.18	5.12	1.90
Enterprise Value to Revenue (EV/Rev)	0.00	190.29	158.85	70.83	49.93	72.18	73.06	127.98	107.16	20.27	15.76
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.03	1.71	2.03	0.76	0.67	0.80	3.48	1.16	0.81	0.86
Long-Term Debt to Equity	0.00	0.00	1.69	2.03	0.76	0.65	0.78	3.47	1.03	0.76	0.69
Financial Leverage	-0.26	-0.34	-0.13	0.06	-0.43	-0.50	-0.36	0.74	-0.20	-0.62	-0.28
Leverage Ratio	1.37	1.40	3.48	3.81	1.90	1.74	2.32	4.47	2.24	1.89	1.97
Compound Leverage Factor	1.37	1.44	3.48	3.82	1.77	1.65	2.21	4.42	1.97	1.79	1.88
Debt to Total Capital	0.39%	2.44%	63.05%	66.97%	43.09%	40.18%	44.47%	77.67%	53.67%	44.67%	46.34%
Short-Term Debt to Total Capital	0.39%	2.44%	0.59%	0.07%	0.05%	1.10%	0.94%	0.27%	5.95%	2.71%	9.56%
Long-Term Debt to Total Capital	0.00%	0.00%	62.46%	66.90%	43.05%	39.09%	43.53%	77.40%	47.72%	41.95%	36.78%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	13.13%	7.12%	7.71%	4.49%	3.82%	3.90%	2.43%	10.81%	12.37%	1.80%
Common Equity to Total Capital	99.61%	84.43%	29.84%	25.33%	52.42%	56.00%	51.62%	19.90%	35.52%	42.97%	51.86%
Debt to EBITDA	34.94	-0.03	-1.14	-1.22	-1.16	-1.05	-1.05	-0.97	-1.04	-1.30	-1.43
Net Debt to EBITDA	-2,325.03	0.46	0.09	-0.04	0.72	0.84	0.56	-0.30	0.08	1.03	0.42
Long-Term Debt to EBITDA	0.00	0.00	-1.13	-1.22	-1.16	-1.02	-1.03	-0.97	-0.92	-1.22	-1.14
Debt to NOPAT	0.00	-0.04	-1.75	-1.96	-2.00	-1.86	-1.84	-4.26	-3.76	-5.06	-4.80
Net Debt to NOPAT	0.00	0.66	0.13	-0.06	1.24	1.49	0.97	-1.33	0.28	4.02	1.40
Long-Term Debt to NOPAT	0.00	0.00	-1.73	-1.96	-2.00	-1.81	-1.80	-4.25	-3.34	-4.75	-3.81
Altman Z-Score	0.00	4.54	2.80	1.37	2.28	4.12	3.89	0.67	3.76	1.36	0.83
Noncontrolling Interest Sharing Ratio	0.00%	8.85%	19.26%	23.33%	6.55%	8.29%	9.74%	15.07%	18.65%	19.75%	3.84%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.05	1.85	3.57	4.00	7.55	9.31	7.21	14.72	6.14	12.23	4.39
Quick Ratio	0.88	1.43	3.31	3.59	7.02	8.87	6.92	14.30	5.74	11.72	4.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.15	-6.75	-15	-20	-20	-18	-21	-52	-76	-88	-215
Operating Cash Flow to CapEx	-95.85%	-180.27%	-238.43%	-195.45%	-107.93%	-284.25%	-137.27%	-439.39%	-281.35%	-744.34%	-289.39%
Free Cash Flow to Firm to Interest Expense	0.00	-56.91	-1,119.13	-295.87	-216.23	-207.08	-236.29	-639.13	-523.60	-339.85	-124.09
Operating Cash Flow to Interest Expense	0.00	-17.35	-215.44	-74.19	-53.21	-44.21	-36.37	-96.59	-60.65	-68.66	-10.27
Operating Cash Flow Less CapEx to Interest Expense	0.00	-26.98	-305.79	-112.15	-102.51	-59.77	-62.87	-118.57	-82.20	-77.88	-13.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.02	0.06	0.08	0.07	0.07	0.06	0.05	0.05	0.08	0.08
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	8.98	8.42	7.87	0.93	2.57	17.46
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.86	35.13	25.92
Fixed Asset Turnover	0.00	0.05	0.00	0.00	0.22	0.25	0.22	0.20	0.31	0.85	0.46
Accounts Payable Turnover	0.00	0.24	0.00	0.00	2.05	2.39	1.29	1.11	2.47	6.03	4.98
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	40.67	43.34	46.40	391.55	142.25	20.91
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	41.18	10.39	14.08
Days Payable Outstanding (DPO)	0.00	1,530.92	0.00	0.00	178.36	152.99	282.61	330.10	147.64	60.49	73.35
Cash Conversion Cycle (CCC)	0.00	-1,530.92	0.00	0.00	-178.36	-112.33	-239.27	-283.69	285.09	92.15	-38.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6.39	11	11	15	22	24	26	59	88	94	224
Invested Capital Turnover	0.00	0.05	0.22	0.30	0.24	0.24	0.23	0.12	0.15	0.40	0.22
Increase / (Decrease) in Invested Capital	6.39	3.93	11	15	16	12	15	44	66	71	197
Enterprise Value (EV)	0.00	82	202	163	169	299	322	586	898	483	424
Market Capitalization	0.00	87	201	158	185	323	338	552	884	593	490
Book Value per Share	$0.28	$0.33	$0.22	$0.21	$0.58	$0.67	$0.60	$0.34	$0.81	$1.84	$2.61
Tangible Book Value per Share	$0.28	$0.27	$0.15	$0.15	$0.53	$0.63	$0.55	$0.29	$0.72	$1.75	$2.54
Total Capital	8.67	19	35	43	74	86	82	127	209	475	557
Total Debt	0.03	0.47	22	29	32	34	37	98	112	212	258
Total Long-Term Debt	0.00	0.00	22	29	32	33	36	98	100	199	205
Net Debt	-2.25	-7.44	-1.67	0.86	-20	-28	-19	31	-8.35	-168	-76
Capital Expenditures (CapEx)	0.68	1.14	1.25	2.62	4.48	1.32	2.31	1.80	3.15	2.40	6.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.13	-2.60	-4.84	-4.17	-2.87	-2.27	-4.35	27	44	47	-1.64
Debt-free Net Working Capital (DFNWC)	0.16	5.31	19	24	49	60	52	95	158	380	292
Net Working Capital (NWC)	0.13	4.84	19	24	49	59	51	95	146	367	238
Net Nonoperating Expense (NNE)	1.46	1.35	2.89	3.66	3.55	3.87	2.89	67	2.42	46	-10
Net Nonoperating Obligations (NNO)	-2.25	-7.44	-1.67	0.86	-20	-28	-19	31	-8.35	-168	-76
Total Depreciation and Amortization (D&A)	0.00	0.04	0.20	0.15	0.18	0.05	0.15	0.53	0.30	0.94	3.06
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-600.77%	-380.09%	-181.67%	-84.97%	-54.67%	-98.71%	596.92%	527.00%	196.23%	-6.11%
Debt-free Net Working Capital to Revenue	0.00%	1,225.49%	1,496.08%	1,049.44%	1,439.29%	1,438.74%	1,171.66%	2,074.14%	1,886.15%	1,593.81%	1,083.07%
Net Working Capital to Revenue	0.00%	1,116.86%	1,479.86%	1,048.06%	1,438.31%	1,416.08%	1,154.07%	2,066.67%	1,738.22%	1,539.78%	885.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.14)	$0.00	$0.00	$0.00	($0.12)	$0.00	($0.12)	($1.03)	($0.15)	($0.81)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	48.77M	33.07M	51.76M	66.69M	61.53M	55.67M	69.48M	73.01M	88.55M	83.01M	121.00M
Adjusted Diluted Earnings per Share	($0.14)	$0.00	$0.00	$0.00	($0.12)	$0.00	($0.12)	($1.03)	($0.15)	($0.81)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	48.77M	33.07M	51.76M	66.69M	61.53M	55.67M	69.48M	73.01M	88.55M	83.01M	121.00M
Adjusted Basic & Diluted Earnings per Share	($0.14)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.15M	33.07M	44.56M	49.14M	71.39M	72.07M	75.06M	91.91M	110.84M	0.00	125.90M
Normalized Net Operating Profit after Tax (NOPAT)	-2.76	-2.82	-4.07	-5.22	-3.80	-5.35	-5.57	-8.38	-10	-18	-17
Normalized NOPAT Margin	0.00%	-650.35%	-484.36%	-510.64%	-349.69%	-448.41%	-505.32%	-699.13%	-214.27%	-105.13%	-416.78%
Pre Tax Income Margin	0.00%	-964.46%	-834.47%	-867.42%	-677.01%	-759.49%	-774.52%	-6,263.80%	-262.19%	-379.04%	-639.64%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-34.26	-508.48	-128.00	-86.57	-112.46	-102.80	-927.90	-99.40	-255.37	-16.23
NOPAT to Interest Expense	0.00	-23.76	-295.21	-75.57	-41.81	-62.96	-63.87	-102.42	-71.73	-67.36	-10.08
EBIT Less CapEx to Interest Expense	0.00	-43.89	-598.83	-165.96	-135.87	-128.02	-129.29	-949.88	-120.96	-264.60	-19.78
NOPAT Less CapEx to Interest Expense	0.00	-33.38	-385.57	-113.53	-91.11	-78.51	-90.37	-124.40	-93.29	-76.59	-13.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-3.46%	0.00%	-0.24%	-8.22%	-11.25%	0.00%	-6.83%	-7.93%	-11.24%	0.00%

Financials Breakdown Chart

Key Financial Trends

ASP Isotopes (NASDAQ: ASPI) has seen a major transformation over the last several years, with revenue growing quickly and the balance sheet expanding dramatically, but the company is still not profitable and is burning significant cash. The latest quarter showed continued top-line growth, yet losses remained wide and operating cash flow stayed deeply negative.

In Q1 2026, revenue was $4.2 million, up from $1.1 million in Q1 2025 and far above the near-zero revenue levels seen in early 2023. That said, operating expenses were much larger than gross profit, resulting in an operating loss of $24.9 million and a net loss of $7.1 million. The gap between revenue growth and profitability remains a key issue for investors.

The company’s cash position is strong on the surface. As of March 31, 2026, ASP Isotopes reported $207.3 million in cash and equivalents plus $83.2 million in short-term investments, along with total assets of $587.7 million. However, that liquidity came after heavy financing and investing activity, and the business still generated negative operating cash flow of $17.8 million in Q1 2026.

Over the broader trend period, ASPI’s revenue has generally improved:

Revenue rose from $0.8 million in Q1 2024 to $1.1 million in Q1 2025 and $4.2 million in Q1 2026.
Gross profit improved sharply in recent quarters, including $1.7 million in Q1 2026 versus just $327,000 in Q1 2025.
The balance sheet shows substantial liquidity, with more than $290 million in cash and short-term investments combined as of Q1 2026.
Total equity and noncontrolling interests increased to $299.0 million in Q1 2026 from $45.7 million in Q1 2025, reflecting a much larger capital base.

There are also signs that the business has been scaling, but not yet efficiently enough:

Revenue growth has been inconsistent quarter to quarter, with some sharp jumps followed by weaker periods.
The company has relied on both debt and equity financing in recent periods to support operations and expansion.
Depreciation increased to $3.1 million in Q1 2026, which likely reflects a much larger asset base and prior capital spending.
Weighted average shares outstanding have risen sharply over the last year, which can dilute per-share value for common shareholders.

On the negative side, the income statement still shows a company far from break-even:

Q1 2026 net loss was $7.1 million, and the company has posted losses in every quarter shown.
Operating expenses in Q1 2026 were $26.6 million, far above gross profit of $1.7 million.
Operating cash flow was negative $17.8 million in Q1 2026, indicating the core business is still consuming cash.
In Q1 2026, the company spent heavily on acquisitions and investments, including $45.8 million on acquisitions and $45.4 million on investments.
The company’s financing history suggests ongoing dependence on external capital, including large equity issuances in 2025.

Bottom line: ASP Isotopes has clearly grown its revenue base and built a much stronger balance sheet than it had in 2023 and early 2024. But investors should note that the company is still operating at a loss and burning cash, so the key question is whether revenue growth can eventually outpace the very high operating cost structure. Until then, the stock remains a high-risk, execution-driven story.

07/18/26 12:28 AM ETAI Generated. May Contain Errors.

ASP Isotopes Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ASP Isotopes' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

ASP Isotopes' net income appears to be on an upward trend, with a most recent value of -$159.84 million in 2025, rising from -$4.95 million in 2022. The previous period was -$32.42 million in 2024. Check out ASP Isotopes' forecast to explore projected trends and price targets.

ASP Isotopes' total operating income in 2025 was -$59.91 million, based on the following breakdown:

Total Gross Profit: $3.41 million
Total Operating Expenses: $63.31 million

Over the last 3 years, ASP Isotopes' total revenue changed from $0.00 in 2022 to $23.85 million in 2025, a change of 2,384,900,000.0%.

ASP Isotopes' total liabilities were at $235.12 million at the end of 2025, a 444.5% increase from 2024, and a 8,677.1% increase since 2022.

In the past 3 years, ASP Isotopes' cash and equivalents has ranged from $2.39 million in 2022 to $279.57 million in 2025, and is currently $279.57 million as of their latest financial filing in 2025.

Over the last 3 years, ASP Isotopes' book value per share changed from 0.37 in 2022 to 1.84 in 2025, a change of 402.7%.

Related Companies

Financial statements for NASDAQ:ASPI last updated on 5/26/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Financials

Financials Breakdown Chart

Key Financial Trends

ASP Isotopes Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Financials

Annual Income Statements for ASP Isotopes

Quarterly Income Statements for ASP Isotopes

Annual Cash Flow Statements for ASP Isotopes

Quarterly Cash Flow Statements for ASP Isotopes

Annual Balance Sheets for ASP Isotopes

Quarterly Balance Sheets for ASP Isotopes

Annual Metrics And Ratios for ASP Isotopes

Quarterly Metrics And Ratios for ASP Isotopes

Financials Breakdown Chart

Key Financial Trends

ASP Isotopes Financials - Frequently Asked Questions

When does ASP Isotopes' financial year end?

How has ASP Isotopes' net income changed over the last 3 years?

What is ASP Isotopes' operating income?

How has ASP Isotopes' revenue changed over the last 3 years?

How much debt does ASP Isotopes have?

How much cash does ASP Isotopes have?

How has ASP Isotopes' book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools